Record growth for DHL healthcare services in Asia
DHL handled a record volume of healthcare shipments in Asia last year, with 7% growth in the transportation of pharmaceuticals, vaccines and medical equipment, according to a senior official from the logistics company.
“Two major factors driving this growth are the rising demand for healthcare in fast-expanding economies such as China and India, as well as the rapidly ageing populations in countries such as Japan, South Korea, Australia, Taiwan and Singapore,” stated Sue Arden, vice president of global customer solutions at DHL Asia Pacific’s Life Sciences & Healthcare division.
“The growth trend is not surprising given the increasing demand for quality healthcare and affluence in Asia. By 2014, China and India will make up 50 percent of the world’s population,” she added.
According to Datamonitor, pharmaceutical sales in Asia Pacific amounted to USD$124.3 billion in 2009, representing 19.3 per cent of global sales. Sales are projected to grow steadily at a compound annual growth rate (CAGR) that exceeds 4.2 per cent from 2009 to 2014, reaching USD$153 billion.
“The establishment of DHL’s first China Competence Centre in Pudong International Airport, Shanghai and a second scheduled to open within 2010 in Tianjin is a clear testament to the growing demand and opportunity we see in this sector,” stated Arden.